Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

An update from Piramal Pharma Limited ( ($IN:PPLPHARMA) ) is now available. Piramal Pharma Limited announced the completion of a significant ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

The strategy clearly defines the goal of turning Vietnam into a centre for high-value pharmaceutical production in the region, ensuring access to drugs at reasonable costs, improving the capacity to ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant ...

The pharmaceutical industry stands at a critical juncture. To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered technologies is ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.